Nomura Holdings
GPCR icon

Nomura Holdings’s Structure Therapeutics GPCR Stock Holding History

Nomura Holdings’s Portfolio GPCR Stock Details GPCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.23M Buy
+22,873
New +$1.01M ﹤0.01% 1286
2024
Q3 		– Sell
-7,009
Closed -$275K – 1720
2024
Q2 		$275K Buy
+7,009
New +$288K ﹤0.01% 1490

Other funds holding GPCR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Nomura Holdings's GPCR Position: Q2 2026 in Review

Nomura Holdings opened a new position in Structure Therapeutics (GPCR) in Q2 2026: 22,873 shares worth $1.23M. The stake represents ﹤0.01% of the portfolio and ranks #1286 among its holdings. This is a return to the name: Nomura Holdings previously reported a position in GPCR as recently as Q2 2024.

Nomura Holdings first reported a position in GPCR in Q2 2024 and has held it in 2 quarters since. 191 funds tracked by Wall St. Rank hold GPCR as of Q2 2026.

  • Nomura Holdings held 22,873 shares of Structure Therapeutics worth $1.23M as of Q2 2026.
  • Structure Therapeutics was a new Nomura Holdings position in Q2 2026.
  • Structure Therapeutics made up ﹤0.01% of Nomura Holdings's portfolio in Q2 2026, its #1286 holding.
  • Nomura Holdings first reported a position in Structure Therapeutics in Q2 2024 and has held it in 2 quarters since.
  • 191 funds tracked by Wall St. Rank held Structure Therapeutics as of Q2 2026.

Based on Nomura Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.